Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)…
SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ -- At the 2025 Transcatheter Cardiovascular Therapeutics® (TCT) Conference, Dr. Jarrod Frizzell of The…
PARIS, Sept. 17, 2025 /PRNewswire/ -- A new international study presented today at the European Academy of Dermatology and Venereology (EADV)…
LONDON, July 21, 2025 /PRNewswire/ -- People in low-income countries are twice as generous as those in high-income countries when it…
DRESDEN, Germany, June 5, 2025 /PRNewswire/ --KINECTRICS announced today a significant expansion of its high-voltage (HV) cable field testing capabilities…